Skip to content

Laser Speckle Imaging for Wound Perfusion Monitoring (WoundImager)

Laser Speckle Imaging for Wound Perfusion Monitoring (WoundImager)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01675583
Enrollment
20
Registered
2012-08-30
Start date
2012-08-31
Completion date
2013-04-30
Last updated
2013-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds and Injuries

Keywords

Diabetic Wounds, Hyperbaric Oxygen, Laser Speckle Imaging, Hyperbaric Oxygenation

Brief summary

The purpose of this study is to investigate the efficacy of an optical device designed and developed to quantitatively monitor blood flow velocity of wound sites. It is hypothesized that the blood flow velocity of the wound site will provide critical information on the efficacy of hyperbaric oxygen therapy.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
CW Optics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects age 21 or older with the following types of wounds and who are able to comply with the study requirements: * Necrotizing fasciitis * Compromised/failed skin grafts/flaps * Chronic refractory osteomyelitis * Soft tissue radiation necrosis * Diabetic wounds, lower extremity * Acute peripheral arterial insufficiency * Crush injury * Venous leg disease * Pressure ulcer * Other chronic, non-healing wounds * Subjects must have signed the Informed Consent Forms.

Exclusion criteria

* Female subjects who are pregnant or nursing. * Anyone who is unable to give written informed consent * Subjects with end-stage renal disease or who require peritoneal or hemodialysis. * Subjects with current malignancies.

Design outcomes

Primary

MeasureTime frameDescription
Blood flow velocity measurements5 monthsEffectiveness of blood flow velocity measurements of wound sites to assess tissue viability with a novel optical device. Comparison between the responses of patients treated with hyperbaric oxygen therapy and those treated by other means will be made.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026